Skip to the page

Data / Form D filings / Correlia Biosystems, Inc.

Correlia Biosystems, Inc.: Form D filings

Correlia Biosystems, Inc., a biotechnology company in Berkeley, CA, filed 2 Form D notices with the SEC between 2020 and 2023. The latest, on May 9, 2023, reports $1.3 million sold of a $3.3 million offering to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
626 BANCROFT WAY, SUITE A, Berkeley, CA, 94710
Phone
(510) 859-4577
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1827990

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 9, 2023New notice$3,250,000$1,254,212$1,995,7882May 1, 2023sec.gov
Oct 16, 2020New notice$9,574,826$9,574,82641Oct 2, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Kittu KolluriDirector
Kursad ArazDirector
Akwasi AporiExecutive Officer, Director

Other biotechnology companies in California that filed recently

Every Form D from the week of May 8, 2023 · All recent filings in California · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Correlia Biosystems, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.